MedPath
HSA Approval

VERAGEL-DMS TABLET

SIN02547P

VERAGEL-DMS TABLET

VERAGEL-DMS TABLET

April 19, 1989

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Therapeutic

Pharmacy Only

Formulation Information

TABLET

**Dosage/Times of administration:** 1 to 2 tablets four times a day, to be taken 1 hour after meals and at bedtime or, as recommended by a doctor.

ORAL

Medical Information

**Indications:** For the management and treatment of hyperacidity, gastritis and peptic ulcer.

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

UNILAB, INC

Active Ingredients

DIMETHICONE

10 mg

Dimethicone

DICYCLOMINE HCl

2.5 mg

Dicyclomine

ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE CO-PRECIPITATE

325 mg

aluminium hydroxide-magnesium carbonate co-precipitate

Documents

Patient Information Leaflets

1.4.4 P300000033030 Veragel DMS Insert_ Singapore - proposed.pdf

Approved: September 10, 2021

Download
© Copyright 2025. All Rights Reserved by MedPath
VERAGEL-DMS TABLET - HSA Approval | MedPath